Abstract: Background: Allergic contact dermatitis to ion nickel (Ni+2) is an inflammatory dermatosis, common in industrialized countries. It involves the activation of nickel-specific T-cells, followed by proliferation and induction of a mixed profile of both proinflammatory and regulatory cytokines, suggesting that several T-cell subtypes (helper -Th and cytotoxic -Tc) are involved. A broader understanding of the cytokine profile may lead to new therapeutic approaches. oBjectives: This study aimed to analyze the cytokines TNF-α, INF-γ, IL-2, IL-4, IL-10, IL-13, IL-17 and IL-23 using the immunohistochemistry technique in order to try to identify their prevalence in chronic and acute eczema of patients with allergic contact dermatitis to Ni+2. Methods: We performed an immunohistochemical study for eight cytokines in 20 patients with Ni+2 allergic contact dermatitis, biopsied at the site of chronic eczema, triggered by the patient's daily contact with Ni+2, and at the site of acute eczema caused by nickel sulfate, 48 hours after applying the contact test. results: The stained samples showed positive results for the eight cytokines studied. TNF-α, IFN-γ, IL-4, IL-13 and IL-17 had a higher prevalence in chronic eczema, IL-2 and IL-23 in acute eczema, and IL-10 presented a similar prevalence in both acute and chronic eczema. However, these prevalences were statistically significant only for IL-4 and IL-13. study liMitations: Small sample size. conclusions: In chronic and acute eczema, we observed the presence of a mixed cytokine profile of the T cell subtypes (Th/ Tc), suggesting that the responses are expressed at the same time.
INTRODUCTION
Contact dermatitis is a frequent inflammatory condition in industrialized countries, with great socioeconomic impact, being one of the most common occupational diseases, mainly in its irritant form. Among the allergic contact dermatites (ACD), those caused by the ion nickel (Ni2+) affect a large part of the general population. 1, 2 ACD results from the immune activation in persons previously sensitized, leading to the development of effector T-cells specific to the antigen, which are mediators of the cutaneous inflammation, causing tissue injury. [3] [4] [5] It is difficult to prevent exposure to Ni2+ since it is present in many common objects for daily use, such as clothing ornaments, jewelry, keys, coins, household utensils, cosmetics, mobile phones, among others. 6 Ni2+ penetrates the skin and activates epithelial cells that produce cytokines and chemokines. Afterwards, there are hyper-reactive immune responses that involve the activation of T-cells and antigen-presenting cells (APCs), such as cutaneous dendritic cells (DCs), [7] [8] [9] whose main role is to recognize and process external antigens and migrate to the draining lymph nodes (dLNs). 3, 4 Such process gives rise to antigen-specific T-CD8+ and CD4+, differentiating into effectors T helper 1 (Th1), T helper 17 (Th17) and cytotoxic T lymphocytes (CTLs). 3, 10, 11 At the same time, regulatory T-CD4+ cells (Tregs), secreting IL-10 develop, inhibiting ACD's inflammatory process and mediating tolerance in non-allergic individuals. [12] [13] [14] Contact allergy is the result of the interaction between environment exposures and individual susceptibility, and only a fraction of the Evaluation of the profile of inflammatory cytokines, through immunohistochemistry, in the skin of patients with allergic contact dermatitis to nickel in the acute and chronic phases The analysis of cytokine production by Ni2+-specific T-cells demonstrated a mixed profile of cytokines. 16 In vitro response to Ni2+ was demonstrated involving the activation of Ni2+-specific T-cells, followed by the proliferation and induction of Th1/Tc1 (IL-2 and IFN-γ), Th2 (IL-4, IL-5, IL-9 and IL-13), Th17/Tc17 (IL-17A,   IL-17F, IL-21, IL-22 and IL-26) cytokines and regulatory cytokines such as IL-10, in the peripheral blood. [16] [17] [18] The stimulus for the differentiation of Th17 cells occurs through pro-inflammatory cytokines such as IL-23, secreted by DCs and macrophages, that stimulate and maintain the production of IL-17, IL-6 and TNF-α. TNF-α can be secreted by activated macrophages, keratinocytes, T lymphocytes and NK (Natural Killer) or monocytes. It is capable of causing keratinocyte apoptosis and has a pro-inflammatory effect. 18, 19 The objective of this study was to study the cytokines acting on Ni2+ ACD using the immunohistochemistry technique to try to identify its prevalence both in chronic eczema triggered by the daily contact of the patient with Ni2+ and the acute eczema triggered by contact tests (CT) with nickel sulfate (NiSO4).
METHODS
The research was an observational, uncontrolled, prospec- Two skin biopsies were taken from each of the 20 patients:
the first from the area of chronic eczema to Ni2+, before applying the CT; and the second from the area of the acute eczema triggered by CT with NiSO4, 48 hours after its application with the readings strong positive (++) or extreme (+++). The samples were preserved in formaldehyde and sent to the laboratory. The tissue sections were placed on microscopy slides and the control tissue was placed on the same slide to validate the reaction and maintain quality standards.
Immunohistochemistry was performed for the following cytokines: tumor necrosis factor alpha (TNF-α), interferon gamma Statistical analyses were performed using the statistics software STATA version 13. Cytokines displayed an asymmetrical probability distribution and the median was the best indicator to summarize the data. Methodologies used were Shapiro-Wilks test to evaluate if the data came from a normal probability distribution and the non-parametric test of Mann-Whitney verified if the prevalences were similar among chronic and acute eczemas by comparing their medians. [25] [26] [27] The level of significance applied for the tests was of 0.05.
RESULTS
The study was conducted using immunohistochemistry for eight cytokines in 20 cases of Ni2+ ACD, both in the samples of chronic eczema, triggered by the daily contact of the patient with Ni2+, and acute eczema, after 48 hours of the application of the CT. only three slides were excluded for some technical error. The marked samples were positive for cytokines TNF-α, INF-γ, IL-2, IL-4, IL-10, IL-13, IL-17 and IL-23 ( Figure 1 and Table 1 ).
The cytokines studied showed heterogeneous values demon- Table 2 ).
IFN-γ prevalence was higher in chronic eczema (median=0.33), when compared to acute eczema (median=0.12) ( Table 2 ). The heterogeneity of the values was higher in acute eczema (CV=1.78), with the presence of three atypical values ( Figure 2 and Table 2 ).
IL-2 showed a higher prevalence in acute eczema (median=0.40) than in chronic (median=0.32), being the most prevalence cytokine in acute eczema (Table 2) . A higher heterogeneity of the values in acute eczema was also observed (CV=1.10), with the presence of one atypical value ( Figure 2 and Table 2 ).
There was a higher prevalence of IL-4 in chronic eczema (median=0.28), when compared to acute eczema (median=0.04) ( Table 2 ).
In regard to the heterogeneity of the values, it was higher in in acute eczema (CV=1.97), with four atypical values ( Figure 2 and Table 2 ).
IL-10 had a similar prevalence, both in acute and chronic eczema (median=0.01) ( Table 2 ). The heterogeneity of the values was higher in acute eczema (CV=2.23), with the presence of two atypical values ( Figure 2 and Table 2 ).
IL-13 had a higher prevalence in chronic eczema (median=0.08) and in acute eczema, the estimated prevalence was very low, near zero (median=0.00) ( Table 2 ). However, there was a higher heterogeneity of the values in acute eczema (CV=3.01), with the presence of three atypical values ( Figure 2 and Table 2 ).
IL-17 prevalence was higher in chronic eczema (median=0. 19 ) than in acute (median=0.13) ( Table 2 ). The higher heterogeneity of the values was in acute eczema (CV=2.55), with two atypical values ( Figure 2 and Table 2 ).
IL-23 had a higher prevalence in acute eczema (median=0.10), when compared to chronic eczema (median=0.09) ( Table   2 ). There was also a higher heterogeneity of the values in acute eczema (CV=3.33), with two atypical values ( Figure 2 and Table 2 ).
In (Table 3) .
DISCUSSION
Cytokines are important determinants and modulators in immunological conditions, suggesting a central role of antigen-specific cytokines in ACD. In particular, those types secreted by specific Ni2+ T-cells control the expression of ACD to Ni2+. 28 The cytokine pattern generated can vary, depending on the specific Ni2+ T-cell clones involved in the inflammatory reaction. 29 Studies demonstrated that, in the skin with contact eczema, there are differences in the cytokine profile according to the timeline of occurrence of the many participating T-cells. 30 In our study, TNF-α was more prevalent in chronic eczema than in acute eczema, being the most prevalent cytokine in chronic eczema as a consequence of the persistent inflammation that progresses to chronicity after repeat contact with Ni2+. However, this IFN-γ, IL-2, IL-4, IL-10, IL-13, IL-17, IL-23 higher prevalence in chronic eczema was not statistically significant. TNF-α produced mainly by macrophages but keratinocytes, monocytes, neutrophils, T lymphocytes and NK cells also produce it. It has anti-inflammatory properties and can be associated to allergic and irritant contact dermatitis. 19, 31 In the elicitation phase of ACD, TNF-α induces keratinocyte apoptosis and activates vascular endothelial cells in order for them to express adhesion molecules such as ICAM-1 and P-/E-selectin, which guide T-cells in the blood to migrate into tissues, contributing to the local inflammatory process caused by Ni2+. 3, 32 Our data demonstrate that IL-2 had a higher prevalence in acute eczema than in chronic, being the most prevalent cytokine in acute eczema in the biopsy taken 48 hours after provocation with NiSO4. However, this higher prevalence in acute eczema was not statistically significant. There are reports in the literature that IL-2 is a cytokine released in the initial phase of the immune response in patients allergic to Ni2+ and suggestions of positive correlations between the production of IL-2 and the severity of the cutaneous inflammation. 29, 33 Studies in stimulated mononuclear cell cultures in the peripheral blood of patients allergic to Ni2+ yielded significant And, due to the heterogeneity of the values, we cannot state that there the prevalences for IL-10 were statistically equal.
However, more studies are needed for a broader understanding of the cytokine profile in Ni2+ ACD, what could lead to new therapeutic approaches. q amounts after 24 hours. 34 IL-2 is produced by CD4+ T-cells and acts on the cells that produce it, i.e., it acts as an autocrine growth factor. It stimulates growth, differentiation and proliferation of T and B lymphocytes (antibody formation) and NK cells (favoring their cytolytic activity) and is responsible for the clonal expansion of lymphocytes specific to the antigen that is being presented. 35 Our data showed a higher prevalence of IFN-γ, IL-4 and IL-13 in chronic eczema, which is frequently triggered by re-exposure to Ni2+. These prevalences were statistically significant for IL-4 and IL-13; which did not apply to IFN-γ. In our study, biopsies in acute eczemas were collected 48 hours after provocation with NiSO4, from a skin that was never in contact with the antigen, and IFN-γ, IL-4 and IL-13 had low prevalences, probably because they would need more time to be produced. The literature demonstrates that, in stimulated mononuclear cell cultures from the peripheral blood of patients allergic to Ni2+, increased levels of IL-4 were produced after 72 hours. 34 A study with skin of mice with chronic contact hypersensitivity, demonstrated increased accumulation of IFN-γ-producing resident memory antigen-specific CD8+ T-cells. 16, 36, 37 In allergic individuals, there is a proliferative Ni2+-specific T-cell response in contrast to non-allergic patients, and also the production of IFN-γ, IL-4 and IL-13, indicating a mixed Th1 and Th2 cytokine pattern in individuals allergic to Ni2+. 34, 37 IL-13 is a cytokine similar to IL-4, and the cell receptor that recognizes IL-13 can bind IL-4 to IL-13 with high affinity. Therefore, these two interleukins share biological effects. 38 The number of IL-4-producing cells correlates with the number of IL-13-producing cells, suggesting a synergy between Th2-type cytokines. 34 Our data demonstrate that IL-10 had a similar prevalence in acute and chronic eczemas. However, these prevalences were very low in both eczemas. Therefore, the lack of negative regulation of proinflammatory cytokines favored the persistence of the cutaneous inflammatory reaction in chronic eczema frequently triggered by Ni2+. Yet, it was not possible to establish a statistical difference of the prevalences in chronic and acute eczemas and, although the prevalences were very close, due to the heterogeneity of the values we cannot statistically affirm that these prevalences were equal. IL-
